Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide, being a complex peptide, requires a stable environment to maintain its delicate structure
Faced with a limited supply, the body directs amino acids to the heart, liver and other critical organs first
Wegovy highlights of prescribing information, Novo Nordisk (2024) The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon-like peptide-1 receptor agonist therapy, Scientific Reports (2024) Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: A nationwide, population-based cohort study, Frontiers in Pharmacology (2022) Most GLP-1 medications correlated with a lower likelihood of anxiety and depression diagnoses, Epic Research (2024) Dopamine release in the midbrain promotes anxiety, Biological Psychology (2021) Dopamine primes the brain for enhanced vigilance, MIT News (2018) Why your cardiologist may prescribe semaglutide (Wegovy), Yale Medicine (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Retatrutide has been designed to be more effective than Lillys tirzepatide, which is approved for weight loss as Zepbound and diabetes as Mounjaro, Leerink Partners said in a note previewing the readout earlier this month
Enough is enough
GLP-1
US$ 23.27
US$ 27.28
US$ 22.91
US$ 23.22
US$ 20.48
US$ 23.30
